 |
|
Acute Respiratory Distress Syndrome as the Initial Clinical Manifestation of an Antisynthetase Syndrome
Seo-Hyun Kim, I-Nae Park
Tuberc Respir Dis. 2016;79(3):188-192. Published online 2016 Jul 1 DOI: https://doi.org/10.4046/trd.2016.79.3.188
|
|
Citations to this article as recorded by
 Rare presentation of rare disease: Idiopathic inflammatory myositis presenting initially as acute respiratory distress syndrome
Vikas Marwah, Ashok Basnet, Robin Choudhary, Varghese Koshy, V Shrinath, Ajai K. Tentu, Sristhi Tripathi
Lung India.2024; 41(2): 139. CrossRef Immune-Mediated Necrotizing Myopathy Associated With Anti-signal Recognition Particle Antibody Complicated With Acute Respiratory Distress Syndrome: A Report of Two Cases
Da-Wei Fang, Yi-Min Chen
Cureus.2024;[Epub] CrossRef Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review
F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F Da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo
Reumatismo.2023;[Epub] CrossRef Antisynthetase Syndrome: The Classical Phenotype With a Twist
Achilleas Betsikos, Evanthia Gazouni, Spyridoula Bika, Eleni Paschou, Nikolaos Sabanis
Cureus.2023;[Epub] CrossRef PARP-1 Inhibition Repressed Imbalance of Th17 and Treg Cells in Preterm Rats with Intrauterine Infection-Induced Acute Respiratory Distress Syndrome by Reducing the Expression Level of IL-6
Qian Chen, Ensheng Zhang, Chun Wang, Peipei Zhang, Lei Huang, Kalidoss Rajakani
Journal of Healthcare Engineering.2022; 2022: 1. CrossRef Antisynthetase Syndrome Post Shingrix and Pneumovax Vaccinations, Possible Correlation
Alsayed Osman, Ahmad Almusa, Robert Ryad, Bahar Sumbulyuksel
Cureus.2022;[Epub] CrossRef Antisynthetase syndrome – much more than just a myopathy
Aleksandra Halina Opinc, Joanna Samanta Makowska
Seminars in Arthritis and Rheumatism.2021; 51(1): 72. CrossRef Antisynthetase Syndrome associated with mycobacterium tuberculosis infection, presenting as an acute respiratory failure
Amani Ben Mansour, Soumaya Ben Saad, Sadok Yaalaoui, Hedia Bellali, Hafaoua Daghfous, Fatma Tritar
Journal of Lung, Pulmonary & Respiratory Research.2021; 8(1): 13. CrossRef Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies
Toyoshi Yanagihara, Kunihiro Suzuki, Ayaka Egashira, Naruhiko Ogo, Tatsuma Asoh, Tsukasa Nara, Kensaku Takatsuki, Seiji Yoshizawa, Sy Giin Chong, Naoki Hamada, Takashige Maeyama
Respiratory Medicine Case Reports.2020; 31: 101272. CrossRef Pulmonary involvement in antisynthetase syndrome
Michela Gasparotto, Mariele Gatto, Francesca Saccon, Anna Ghirardello, Luca Iaccarino, Andrea Doria
Current Opinion in Rheumatology.2019; 31(6): 603. CrossRef Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study
Constance Vuillard, Marc Pineton de Chambrun, Nicolas de Prost, Claude Guérin, Matthieu Schmidt, Auguste Dargent, Jean-Pierre Quenot, Sébastien Préau, Geoffrey Ledoux, Mathilde Neuville, Guillaume Voiriot, Muriel Fartoukh, Rémi Coudroy, Guillaume Dumas, E
Annals of Intensive Care.2018;[Epub] CrossRef Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies
Jingli Shi, Shanshan Li, Hanbo Yang, Yamei Zhang, Qinglin Peng, Xin Lu, Guochun Wang
The Journal of Rheumatology.2017; 44(7): 1051. CrossRef
|